Boehringer Ingelheim GmbH
All Topics
Find news about people
Find news on alumni of any org
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions


Change Feed
Boehringer Ingelheim GmbH
... companies including many key and niche players such as: Allergan plc (Ireland)Boehringer Ingelheim GmbH (Germany)Daiichi Sankyo Company Limited (Japan)Eli Lilly and Company (USA)Innovative Med Concepts, ...
... 2018 Saniona, a leading biotech company within ion-channel research, today announced that Boehringer Ingelheim has selected the first candidate for pre-clinical and clinical development under ...
... players such as: Abbott Laboratories (USA)Allergan, Inc. (USA)Amgen, Inc. (USA)AstraZeneca Plc. (UK)Boehringer Ingelheim GmbH (Germany)Bristol-Myers Squibb Company (USA)Eli Lilly and Company (USA)F. Hoffmann-La Roche Ltd ...
... Metavention, NovaTarg, Novo Nordisk A/S, Sanofi, VTV Therapeutics. Research Support; Self; Boehringer Ingelheim GmbH, Johnson & Johnson Services, Inc., Theracos, Inc.. Other Relationship; Self; Shenzhen ...
... Self; Merck Sharp & Dohme Corp. H. Colhoun:Research Support; Self; AstraZeneca, Boehringer Ingelheim GmbH. Stock/Shareholder; Self; Bayer AG. Research Support; Self; Eli Lilly and Company. ...
... Drug Designation for E4 AstraZeneca Receives Orphan Designation from EMA for inebilizumab Boehringer Ingelheim gets FDA Orphan Drug Status for BI 836858 Biostage gets FDA ...
... Therapeutics, and Eisai Co, Ltd. are the key players in the market. Boehringer Ingelheim, Merck & Co, Nova Nordisk, Pfizer, Rhythm Pharmaceuticals, Zafgan, and Takeda ...
... (USA)Amgen, Inc. (USA)AstraZeneca Plc. (UK)Bayer AG (Germany)Biogen Inc. (USA)BioMarin Pharmaceutical Inc. (USA)Boehringer Ingelheim GmbH (Germany)Bristol-Myers Squibb Company (USA)Celgene Corp. (USA)CEL-SCI Corporation (USA)Concordia International Corp. (Canada)Eli ...
Subscribe now for full coverage on Boehringer Ingelheim GmbH
Start My Free Trial